Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent corporate updates.

A Counter-Terrorism Department (CTD) official was martyred and two others were injured when a powerful explosion ripped ...

Q3 2025 Earnings Call Transcript November 4, 2025 Exagen Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, ...

Q3 2025 Management View CEO John Aballi reported, "Q3 was the strongest quarter in Exagen's history, driven by robust volume growth and continued execution across our commercial, scientific and ...

Exagen reported a record-breaking fourth-quarter revenue of $17.2 million, marking the highest quarter in the company’s history. This represents a nearly 40% increase over the third quarter of 2024, ...

CARLSBAD, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming ...

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...

The term "data science" has become more tech-savvy industries. But for data science specialist Pramath Parashar, it is also ...

Authorities sealed off the Islamabad High Court after an explosion injured several, prompting a citywide security alert and ...

President Donald Trump said he has instructed the Pentagon to “immediately” begin nuclear weapons testing. Atomic Archive President Donald Trump said the United States will resume nuclear weapons ...

Just a handful of days after announcing her surprise retirement from the sport, reports from Australia indicate that Ariarne Titmus has officially been withdrawn from the World Anti-Doping Agency’s ...

Hyundai is gearing up to diversify its product portfolio for the global market, with an updated version of the Hyundai Venue N Line. The sporty version of the Venue SUV has now been spotted testing in ...